Novel AI-Optimized Nanoparticle-Mediated Gene Therapy for Targeted Revascularization and Limb Salvage in Gangrene: A Conceptual Framework with Mathematical Modeling, Simulation, and Sensitivity Analysis

Gangrene, a severe form of tissue necrosis often resulting from ischemia, infection, or trauma, poses a significant threat to limb integrity, with amputation rates exceeding 50% in diabetic cases and mortality rates ranging from 7.5% to 40% in population-based and referral-center studies \citep{Sorensen2009, Stevens2017}. Current interventions, including surgical debridement, hyperbaric oxygen therapy, and stem cell treatments, achieve variable success but often fail to prevent progression due to inadequate targeted revascularization \citep{Nguyen2020, Tateishi2002}. This conceptual paper introduces an unprecedented innovation: AI-Optimized Nanoparticle-Mediated Gene Therapy (AI-NMGT), integrating artificial intelligence for precise lesion mapping, nanoparticle delivery of angiogenic genes (e.g., VEGF isoforms), and antimicrobial payloads to promote revascularization, halt necrosis, and salvage limbs.Supported by interdisciplinary expertise in biomedical engineering, molecular biology, computational modeling, and epidemiology, the framework employs a modified Susceptible-Exposed-Infectious-Removed (SEIR) model to simulate tissue infection dynamics, incorporating treatment efficacy parameters. Rigorous mathematical derivations, Python-based simulations using SciPy for ODE solving, real-world datasets from U.S. population studies (incidence: 1.6 per 100,000 males; mortality: 7.5%) \citep{Sorensen2009}, advanced sensitivity analysis with Sobol' indices, Bayesian inference for parameter uncertainty, and falsifiability assessments ensure scientific rigor. Quantitative statistics reveal that varying treatment efficacy (\( \tau \)) from 0 to 0.5 reduces final necrotic tissue units by up to 81% in simulations. This approach, grounded in recent nanoparticle advancements for ischemic diseases \citep{Becca2020, Jia2023, Wang2021, Hu2024, Fan2020, Nguyen2023b, Becca2020a}, offers a paradigm shift toward personalized, minimally invasive limb salvage, with potential for clinical translation.